Overview
- Palantir reported a blowout quarter with revenue up roughly 85% to about $1.63 billion and management raised full-year guidance after U.S. commercial sales surged, driven by adoption of its Artificial Intelligence Platform (AIP).
- Investors have pushed the stock sharply lower in 2026 despite upgrades from some firms, leaving shares well below their November 2025 peak and reflecting concern that current multiples assume many years of sustained high growth.
- Analysts and valuation models say today’s price implies unusually strong multi‑year revenue gains — one model calculates roughly 33% annual growth for seven years to justify the multiple — and several firms call the stock extremely expensive for software.
- Competitors and supplier risks are central worries: firms point to OpenAI, Anthropic and Databricks building deployment and data layers, and Palantir depends on third‑party models that could shift access or pricing.
- Regulatory and execution risks add near‑term uncertainty, including a planned UK review of its NHS contract, recent insider selling that rattled sentiment, and the challenge of converting a large deal backlog into steady margin‑preserving revenue.